Dear Colleague

It is with great pleasure that we invite you to attend The 4th International Virtual Congress on Controversies in Fibromyalgia (Fibromyalgia2022) which will take place 25-26 May 2022.

Even as our understanding regarding the pathogenesis and neuroscience underlying fibromyalgia and chronic pain rapidly expand and proliferate in recent years, heated controversies remain regarding many aspects of fibromyalgia, regarding its place in medicine and society and regarding the best ways to alleviate suffering.

Fibromyalgia2022  will again expose and shed constructive light on some of these more central controversies, honoring diversity of opinion as well as attempting to forge understanding and a basis for collaboration down the road.

The Congress will welcome researchers, clinicians, Fibromyalgia specialists, pain specialists, treatment experts, rehabilitation & occupational health specialists and other professionals.

The congress will focus on the following key areas:

  • Neuro-biological Underpinnings of Fibromyalgia and Centralized Pain
  • Classification, Diagnosis, Epidemiology and the Evolving Concept of Fibromyalgia
  • Genetics, Pharmacogenentics, and Epigenetics
  • Treatment of Fibromyalgia
  • Complex CNS
  • “Transparent Pain”: How Society Deals with Fibromyalgia

We look forward to meeting you online at Fibromyalgia2022.

Sincerely,

Prof. Jacob Ablin
Tel-Aviv Sourasky Medical Center, Israel

Congress Co-Chair

 

Prof. Piercarlo Sarzi-Puttini
L. Sacco University Hospital, Milan, Italy

Congress Co-Chair

Skip to content
Broadcast Time Zone is Central European Summer Time (CEST)

All registered delegates have been sent an invitation with personal link to set their profile and enter the virtual Congress platform. Your personal link will only be valid until the end of the Congress.  In order to view the Congress lectures and panel discussions, delegates must enter the virtual Congress platform and set their profile before the end of the Congress. For any additional information contact: rachel@bioevents-congress.com